1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Zuberitamab 1000mg: new trials by email Literature Review of Zuberitamab 1000mg trials Research Report on Zuberitamab 1000mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy Zuberitamab 600mg, Zuberitamab 1000mg, cyclosporine - Primary Membranous Nephropathy | Phase 2 | Active not recruiting | BioRay Pharmaceutical Co., Ltd. | 135 | 2024-11-13 | 2025-11-20 |
BioRay Pharmaceutical Co., Ltd. (1)
China (1)